Search

Search Constraints

You searched for: Author/Creator DeSear, Kathryn

Search Results

1. 1101. Implementing a Beta-Lactam Therapeutic Drug Monitoring Program: Experience from a Large Academic Medical Center. (4th December 2021)

2. 1257. Re-Evaluation of Cefepime or Piperacillin-Tazobactam to Decrease Use of Carbapenems in ESBL-Producing Enterobacterales Urinary Tract Infections (REDUCE-UTI). (4th December 2021)

4. 1576. Re-Evaluation of cefepime or piperacillin-tazobactam to Decrease Use of Carbapenems in ESBL-Producing Enterobacterales BloodStream Infections (REDUCE-BSI). (31st December 2020)

5. 708: USE OF BETA-LACTAM THERAPEUTIC DRUG MONITORING IN THE PEDIATRIC INTENSIVE CARE UNIT. (16th December 2021)

6. 708: USE OF BETA-LACTAM THERAPEUTIC DRUG MONITORING IN THE PEDIATRIC INTENSIVE CARE UNIT. (January 2022)

8. 952: BETA-LACTAM EXPOSURE IN ICU PATIENTS AND ASSOCIATED OUTCOMES: A PROSPECTIVE OBSERVATIONAL STUDY. (16th December 2021)